The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.
Screening for Coronary Artery Disease in Patients With Diabetes
Abstract
Coronary artery disease (CAD) accounts for a large fraction of the morbidity, mortality, and cost of diabetes. Recognizing this, nearly 10 years ago the American Diabetes Association published a consensus recommendation that clinicians consider a risk factor–guided screening approach to early diagnosis of CAD in both symptomatic and asymptomatic patients. Subsequent clinical trial results have not supported those recommendations. Since the prior consensus statement, newer imaging methods, such as coronary artery calcium scoring and noninvasive angiography with computed tomography (CT) techniques, have come into use. These technologies, which allow quantitation of atherosclerotic burden and can predict risk of cardiac events, might provide an approach to more widespread coronary atherosclerosis screening. However, over this same time interval, there has been recognition of diabetes as a cardiovascular disease (CVD) equivalent, clear demonstration that medical interventions should provide primary and secondary CVD risk reduction in diabetic populations, and suggestive evidence that percutaneous coronary revascularization may not provide additive survival benefit to intensive medical management in patients with stable CAD. This additional evidence raises the question of whether documenting asymptomatic atherosclerosis or ischemia in people with diabetes is warranted. More data addressing this issue will be forthcoming from the BARI 2-D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial. Until then, for patients with type 2 diabetes who are asymptomatic for CAD, we recommend that testing for atherosclerosis or ischemia, perhaps with cardiac CT as the initial test, be reserved for those in whom medical treatment goals cannot be met and for selected individuals in whom there is strong clinical suspicion of very-high-risk CAD. Better approaches to identify such individuals based on readily obtained clinical variables are sorely needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Participating in leisure-time activity and avoiding extended sedentary periods may help prevent T2D for those at risk959,960 and may also aid in glycemic control for those with DM.961–964”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [959]
Citations
Cites
Turner, R. C., Fox, C., Matthews, McElroy, H. H., Cull, C. A., Holman, R. R., Neil, P., Hadden, D. R., Wright, D., Manley, E., et al. (1998) · The Lancet · Cited by 8,419
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 1×
“Furthermore, intervention directed at multiple risk factors significantly improves cardiovascular prognosis (44).”
BackgroundEconomic Costs of Diabetes in the U.S. in 2002
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.3.917 · Cited by 4,147 · cited 1×
“A s coronary artery disease (CAD) is the major cause of morbidity, mortality, and medical cost of diabetes (1), early diagnosis of CAD to prevent progression and clinical events has intuitive appeal.”
BackgroundColhoun, H. M., Betteridge, D. J., Durrington, P. N., Hitman, G. A., W Neil, H. A., Livingstone, S. J., Thomason, M. J., Mackness, M. I., Charlton-Menys, V., & Fuller, J. H. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16895-5 · Cited by 3,755
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440 · cited 1×
“Microalbuminuria predicts increased risk for vascular disease complications (15,17,27,28), as well as for the progression to overt nephropathy, in patients with type 1 or type 2 diabetes.”
Background(2000) · PubMed · Cited by 2,095
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Pyörälä, K., Pedersen, T. R., Kjekshus, J., Faergeman, O., Olsson, A. G., Thorgeirsson, G., & The Scandinavian Simvastatin Survival Study (4S) Group (1997) · Diabetes Care · doi:10.2337/diacare.20.4.614 · Cited by 1,623
Hachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003) · Circulation · doi:10.1161/01.cir.0000072790.23090.41 · Cited by 1,563
Budoff, M. J., Achenbach, S., Blumenthal, R. S., Carr, J. J., Goldin, J. G., Greenland, P., Guerci, A. D., Lima, J. A. C., Rader, D. J., Rubin, G. D., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.178458 · Cited by 1,398
Mann, J. F. E., Gerstein, H. C., Pogue, J., Bosch, J., Yusuf, S., & for the HOPE Investigators (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00007 · Cited by 1,372
Hendel, R. C., Patel, M. R., Kramer, C. M., Poon, M., Hendel, R. C., Carr, J. C., Gerstad, N. A., Gillam, L. D., Hodgson, J. M., Kim, R. J., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.003 · Cited by 1,288
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Aggressive Lipid-Lowering Therapy Compared with Angioplasty in Stable Coronary Artery Disease
Pitt, B., Waters, D., Brown, W. V., van Boven, A. J., Schwartz, L., Title, L. M., Eisenberg, D., Shurzinske, L., & McCormick, L. S. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907083410202 · Cited by 946
(2007) · Circulation · doi:10.1161/circulationaha..107.181425 · Cited by 933
Self-citationShaw, L. J., Raggi, P., Schisterman, E., Berman, D. S., & Callister, T. Q. (2003) · Radiology · doi:10.1148/radiol.2283021006 · Cited by 891
Detection of Silent Myocardial Ischemia in Asymptomatic Diabetic Subjects
Wackers, F. J. T., Young, L. H., Inzucchi, S. E., Chyun, D. A., Davey, J. A., Barrett, E. J., Taillefer, R., Wittlin, S. D., Heller, G. V., Filipchuk, N., et al. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.1954 · Cited by 791
Self-citationHyperglycemia and cardiovascular disease in type 2 diabetes.
Laakso, M. (1999) · Diabetes · doi:10.2337/diabetes.48.5.937 · Cited by 747
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179294 · Cited by 638
Prognostic value of coronary artery calcium screening in subjects with and without diabetes
Raggi, P., Shaw, L. J., Berman, D. S., & Callister, T. Q. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.068 · Cited by 608
Peripheral Arterial Disease: Morbidity and Mortality Implications
Golomb, B. A., Dang, T. T., & Criqui, M. H. (2006) · Circulation · doi:10.1161/circulationaha.105.593442 · Cited by 498
Abbott, R. D. (1988) · JAMA · doi:10.1001/jama.260.23.3456 · Cited by 498
Haffner, S. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.22.2661 · Cited by 441
Berman, D. S., Wong, N. D., Gransar, H., Miranda-Peats, R., Dahlbeck, J., Hayes, S. W., Friedman, J. D., Kang, X., Polk, D., Hachamovitch, R., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.042 · Cited by 437
Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus
Bhatt, D. L., Marso, S. P., Hirsch, A. T., Ringleb, P. A., Hacke, W., & Topol, E. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02567-5 · Cited by 409
Anand, D. V., Lim, E., Hopkins, D., Corder, R., Shaw, L. J., Sharp, P., Lipkin, D., & Lahiri, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi808 · Cited by 392
Hachamovitch, R., Hayes, S., Friedman, J. D., Cohen, I., Shaw, L. J., Germano, G., & Berman, D. S. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00125-6 · Cited by 384
Giri, S., Shaw, L. J., Murthy, D. R., Travin, M. I., Miller, D. D., Hachamovitch, R., Borges-Neto, S., Berman, D. S., Waters, D. D., & Heller, G. V. (2002) · Circulation · doi:10.1161/hc5001.100528 · Cited by 367
He, Z.-X., Hedrick, T. D., Pratt, C. M., Verani, M. S., Aquino, V., Roberts, R., & Mahmarian, J. J. (2000) · Circulation · doi:10.1161/01.cir.101.3.244 · Cited by 359
Coronary atherosclerosis in diabetes mellitus
Goraya, T. Y., Leibson, C. L., Palumbo, P. J., Weston, S. A., Killian, J. M., Pfeifer, E. A., Jacobsen, S. J., Frye, R. L., & Roger, V. L. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02065-x · Cited by 354
Self-citationDoobay, A. V., & Anand, S. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000168911.78624.b7 · Cited by 341
American Diabetes Association (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1551 · Cited by 329
Eddy, D. M., & Schlessinger, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3093 · Cited by 260
Schuijf, J. D., Bax, J. J., Shaw, L. J., de Roos, A., Lamb, H. J., van der Wall, E. E., & Wijns, W. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.03.022 · Cited by 255
Self-citationDetection of Coronary Artery Disease in Asymptomatic Patients With Type 2 Diabetes Mellitus
Scognamiglio, R., Negut, C., Ramondo, A., Tiengo, A., & Avogaro, A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.008 · Cited by 249 · cited 2×
“Unfortunately, recent studies have shown that the burden of traditional categorical risk factors does not predict inducible ischemia on nuclear or echocardiographic myocardial perfusion imaging (13,14).”
BackgroundSoedamah-Muthu, S. S., Fuller, J. H., Mulnier, H. E., Raleigh, V. S., Lawrenson, R. A., & Colhoun, H. M. (2006) · Diabetologia · doi:10.1007/s00125-005-0120-4 · Cited by 240
Valensi, P., Sachs, R.-N., Harfouche, B., Lormeau, B., Paries, J., Cosson, E., Paycha, F., Leutenegger, M., & Attali, J.-R. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.339 · Cited by 238
Rajagopalan, N., Miller, T. D., Hodge, D. O., Frye, R. L., & Gibbons, R. J. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.078 · Cited by 237
Self-citationKlein, B. E. K., Klein, R., McBride, P. E., Cruickshanks, K. J., Palta, M., Knudtson, M. D., Moss, S. E., & Reinke, J. O. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.17.1917 · Cited by 233
Schuijf, J. D., Pundziute, G., Jukema, J. W., Lamb, H. J., van der Hoeven, B. L., de Roos, A., van der Wall, E. E., & Bax, J. J. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.092 · Cited by 232
Self-citationComputer Modeling of Diabetes and Its Complications
The Mount Hood 4 Modeling Group (2007) · Diabetes Care · doi:10.2337/dc07-9919 · Cited by 199
Validation of the Archimedes Diabetes Model
Eddy, D. M., & Schlessinger, L. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3102 · Cited by 196
Guzder, R. N., Gatling, W., Mullee, M. A., Mehta, R. L., & Byrne, C. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01494.x · Cited by 174
(1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00699-6 · Cited by 172
Rh, G., Svendsen, K. H., Kasiske, B. L., Keane, W. F., & Mm, W. (1997) · PubMed · Cited by 169
De Lorenzo, A., Lima, R. S. L., Siqueira-Filho, A. G., & Pantoja, M. R. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02702-9 · Cited by 166
Akasaka, T., Yoshida, K., Hozumi, T., Takagi, T., Kaji, S., Kawamoto, T., Morioka, S., & Yoshikawa, J. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00242-8 · Cited by 149
Sorajja, P., Chareonthaitawee, P., Rajagopalan, N., Miller, T. D., Frye, R. L., Hodge, D. O., & Gibbons, R. J. (2005) · Circulation · doi:10.1161/circulationaha.104.525022 · Cited by 145
Self-citationPrognostic stratification of diabetic patients by exercise echocardiography
Elhendy, A., Arruda, A. M., Mahoney, D. W., & Pellikka, P. A. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01199-8 · Cited by 130
Vanzetto, G., Halimi, S., Hammoud, T., Fagret, D., Benhamou, P., Cordonnier, D., Denis, B., & Machecourt, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.19 · Cited by 119
Adler, A., Neil, H. A. W., Manley, S. E., Holman, R. R., & Turner, R. C. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70035-9 · Cited by 97
DIABETIC RETINOPATHY AND CARDIOVASCULAR DISEASE IN TYPE II DIABETICS
Hiller, R., Sperduto, R. D., Podgor, M. J., Ferris, F. L., & Wilson, P. W. F. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114980 · Cited by 93
Donnan, P. T., Donnelly, L. A., New, J. P., & Morris, A. D. (2006) · Diabetes Care · doi:10.2337/dc05-1911 · Cited by 89
Boden, W. E., O’Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M. L., Dada, M. R., Casperson, P. R., Harris, C. L., et al. (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.08.015 · Cited by 88
Mortality After 16 Years for Participants Randomized to the Multiple Risk Factor Intervention Trial
(1996) · Circulation · doi:10.1161/01.cir.94.5.946 · Cited by 88
Rutter, M. K., McComb, J. M., Brady, S., & Marshall, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00777-2 · Cited by 82
Dobutamine Stress Echocardiography in Patients With Diabetes Mellitus
Chaowalit, N., Arruda, A. L., McCully, R. B., Bailey, K. R., & Pellikka, P. A. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.048 · Cited by 63
Diamond, G. A., Kaul, S., & Shah, P. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.09.057 · Cited by 46
Predictors of coronary heart disease and death in NIDDM: The Diabetes Intervention Study experience
Hanefeld, M., Schmechel, H., Schwanebeck, U., & Lindner, J. (1997) · Diabetologia · doi:10.1007/s001250051425 · Cited by 41
Importance of arachidonic acid as a mediator of parathyroid gland response
Canalejo, A., Cañadillas, S., Ballesteros, E., Rodríguez, M., & Almadén, Y. (2003) · Kidney International · doi:10.1046/j.1523-1755.63.s85.4.x · Cited by 34
ADLER, A., Neil, H., Manley, S. E., Holman, R. R., & TURNER, R. (1999) · American Heart Journal · doi:10.1016/s0167-0115(99)90005-4 · Cited by 25
The role of electron beam computed tomography for measuring coronary artery atherosclerosis
Mazzone, T. (2004) · Current Diabetes Reports · doi:10.1007/s11892-004-0006-8 · Cited by 2
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“5, the area of screening asymptomatic diabetic patients for CAD remains unclear, and a recent ADA consensus statement on this issue concluded that routine screening is not recommended (196).”
BackgroundStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Metadata
- Authors
- Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., & Barrett, E. J.
- Affiliations
- Leiden University Medical Center (NL)
- Yale University (US)
- Mayo Clinic (US)
- Northwestern University (US)
- Indiana University Indianapolis (US)
- University of Virginia (US)
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-10-01
- Volume
- 30
- Issue
- 10
- Pages
- 2729-2736
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2108913002
- Cited by
- 251
- References
- 71
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 6 · 2023: 8 · 2022: 6 · 2021: 10 · 2020: 12 · 2019: 6 · 2018: 9 · 2017: 13 · 2016: 11 · 2015: 11 · 2014: 16 · 2013: 23 · 2012: 15
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Cardiac Imaging and Diagnostics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Keywords
- coronary artery disease, diabetes mellitus, cardiovascular risk screening, coronary artery calcium scoring, cardiac CT angiography, atherosclerosis, type 2 diabetes, asymptomatic coronary artery disease, percutaneous coronary intervention, cardiovascular risk reduction
- MeSH terms
- Coronary Disease, Diabetic Angiopathies, Diabetic Neuropathies, Diabetic Retinopathy, Humans, Hyperglycemia, Mass Screening, Risk Assessment, Atherosclerosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.